James Porter

Chief Executive Officer at NUVALENT, INC.

Net worth: 36 M $ as of 30/05/2026

50 year

Consumer Services

Health Technology

Profile

James R.
Porter is President, Chief Executive Officer & Director at Nuvalent, Inc. since 2020, with employment at the company starting in 2017.
Formerly, Dr. Porter was Vice President-Product Development at Infinity Pharmaceuticals, Inc. from 2002 to 2016.
Education includes a doctorate from Boston College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NUVALENT, INC. CLASS A 0.44%	07/06/2026	324,879 ( 0.44% )	36 M $	30/05/2026

James Porter active positions

Companies	Position	Start
NUVALENT, INC.	Chief Executive Officer	31/12/2016

All active positions of James Porter

Former positions of James Porter

Companies	Position	End
INFINITY PHARMACEUTICALS, INC.	Corporate Officer/Principal	30/11/2016

See the detail of James Porter's experience

Training of James Porter

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James Porter's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
College of the Holy Cross (Massachusetts) College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer	Health Technology
Boston College Boston College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nuvalent, Inc. Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer	Health Technology